BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15560113)

  • 1. 15-deoxy-delta12,14-prostaglandin-J2 inhibits expression of eNOS in human endothelial cells.
    Józkowicz A; Nigisch A; Winter B; Weigel G; Hukb I; Dulaka J
    Prostaglandins Other Lipid Mediat; 2004 Oct; 74(1-4):11-28. PubMed ID: 15560113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor gamma ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor gamma-dependent mechanisms.
    Polikandriotis JA; Mazzella LJ; Rupnow HL; Hart CM
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1810-6. PubMed ID: 16020752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclopentenone prostaglandins suppress activation of microglia: down-regulation of inducible nitric-oxide synthase by 15-deoxy-Delta12,14-prostaglandin J2.
    Petrova TV; Akama KT; Van Eldik LJ
    Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4668-73. PubMed ID: 10200320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits IL-1beta-induced cyclooxygenase-2 expression in mesangial cells.
    Sawano H; Haneda M; Sugimoto T; Inoki K; Koya D; Kikkawa R
    Kidney Int; 2002 Jun; 61(6):1957-67. PubMed ID: 12028436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 15-Deoxy-delta12,14-PGJ2, but not troglitazone, modulates IL-1beta effects in human chondrocytes by inhibiting NF-kappaB and AP-1 activation pathways.
    Boyault S; Simonin MA; Bianchi A; Compe E; Liagre B; Mainard D; Bécuwe P; Dauça M; Netter P; Terlain B; Bordji K
    FEBS Lett; 2001 Jul; 501(1):24-30. PubMed ID: 11457450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) signals through retinoic acid receptor-related orphan receptor-alpha but not peroxisome proliferator-activated receptor-gamma in human vascular endothelial cells: the effect of 15d-PGJ2 on tumor necrosis factor-alpha-induced gene expression.
    Migita H; Morser J
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):710-6. PubMed ID: 15662020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator--activated receptor gamma activators inhibit interleukin-1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes.
    Fahmi H; Di Battista JA; Pelletier JP; Mineau F; Ranger P; Martel-Pelletier J
    Arthritis Rheum; 2001 Mar; 44(3):595-607. PubMed ID: 11263774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 15-deoxy-delta 12,14-prostaglandin J2 and laminar fluid shear stress stabilize c-IAP1 in vascular endothelial cells.
    Taba Y; Miyagi M; Miwa Y; Inoue H; Takahashi-Yanaga F; Morimoto S; Sasaguri T
    Am J Physiol Heart Circ Physiol; 2003 Jul; 285(1):H38-46. PubMed ID: 12623786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The peroxisome proliferator-activated receptor gamma ligand 15-deoxy-Delta12,14-prostaglandin J2 induces vascular endothelial growth factor in the hormone-independent prostate cancer cell line PC 3 and the urinary bladder carcinoma cell line 5637.
    Haslmayer P; Thalhammer T; Jäger W; Aust S; Steiner G; Ensinger C; Obrist P
    Int J Oncol; 2002 Oct; 21(4):915-20. PubMed ID: 12239635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 15-deoxy-delta12,14-Prostaglandin J2 inhibits tissue factor expression in human macrophages and endothelial cells: evidence for ERK1/2 signaling pathway blockade.
    Eligini S; Banfi C; Brambilla M; Camera M; Barbieri SS; Poma F; Tremoli E; Colli S
    Thromb Haemost; 2002 Sep; 88(3):524-32. PubMed ID: 12353085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor gamma is required for the inhibitory effect of ciglitazone but not 15-deoxy-Delta 12,14-prostaglandin J2 on the NFkappaB pathway in human endothelial cells.
    Kaplan J; Cook JA; O'Connor M; Zingarelli B
    Shock; 2007 Dec; 28(6):722-726. PubMed ID: 17621259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells.
    Chen ZY; Tseng CC
    Mol Pharmacol; 2005 Nov; 68(5):1203-13. PubMed ID: 16077033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes: evidence for PPARgamma-independent inhibition by 15-deoxy-Delta12,14prostaglandin J2.
    Bianchi A; Moulin D; Sebillaud S; Koufany M; Galteau MM; Netter P; Terlain B; Jouzeau JY
    Arthritis Res Ther; 2005; 7(6):R1325-37. PubMed ID: 16277686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor-gamma ligands regulate endothelial membrane superoxide production.
    Hwang J; Kleinhenz DJ; Lassègue B; Griendling KK; Dikalov S; Hart CM
    Am J Physiol Cell Physiol; 2005 Apr; 288(4):C899-905. PubMed ID: 15590897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Troglitazone and 15-deoxy-delta(12,14)-prostaglandin J2 inhibit shear-induced coupling factor 6 release in endothelial cells.
    Tomita H; Osanai T; Toki T; Sasaki S; Maeda N; Murakami R; Magota K; Yasujima M; Okumura K
    Cardiovasc Res; 2005 Jul; 67(1):134-41. PubMed ID: 15949477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 15-deoxy-delta12,14-prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-kappaB-p300 pathway independent of peroxisome proliferator-activated receptor gamma.
    Giri S; Rattan R; Singh AK; Singh I
    J Immunol; 2004 Oct; 173(8):5196-208. PubMed ID: 15470065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2.
    Ji JD; Kim HJ; Rho YH; Choi SJ; Lee YH; Cheon HJ; Sohn J; Song GG
    Rheumatology (Oxford); 2005 Aug; 44(8):983-8. PubMed ID: 15840591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin-J2 induces synthesis of interleukin-8 by endothelial cells in a PPAR-gamma-independent manner.
    Jozkowicz A; Dulak J; Prager M; Nanobashvili J; Nigisch A; Winter B; Weigel G; Huk I
    Prostaglandins Other Lipid Mediat; 2001 Oct; 66(3):165-77. PubMed ID: 11577781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of hTERT expression plays an important role in 15-deoxy-Delta12,14-prostaglandin J2-induced apoptosis in cancer cells.
    Moriai M; Tsuji N; Kobayashi D; Kuribayashi K; Watanabe N
    Int J Oncol; 2009 May; 34(5):1363-72. PubMed ID: 19360348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-Delta12, 14-prostaglandin J2.
    Bishop-Bailey D; Hla T
    J Biol Chem; 1999 Jun; 274(24):17042-8. PubMed ID: 10358055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.